Revelation Biosciences (NASDAQ:REVBW – Get Free Report) will likely be releasing its results before the market opens on Friday, August 7th. Analysts expect the company to announce earnings of ($0.83) per share for the quarter.
Revelation Biosciences Stock Performance
Shares of NASDAQ:REVBW opened at $0.01 on Wednesday. The firm has a fifty day moving average price of $0.01 and a 200 day moving average price of $0.01. Revelation Biosciences has a fifty-two week low of $0.01 and a fifty-two week high of $0.04.
Revelation Biosciences Company Profile
Revelation Biosciences, Inc (NASDAQ: REVBW) is a clinical-stage molecular diagnostics company focused on the rapid detection of life-threatening bacterial infections. The company leverages next-generation sequencing (NGS) to analyze cell-free microbial DNA in patient blood samples, with an emphasis on early identification of pathogens in bloodstream infections and hospital-acquired pneumonia. By targeting critically ill patients, Revelation Biosciences aims to shorten time to diagnosis and guide more effective antimicrobial therapy.
The company’s technology platform integrates high-throughput DNA sequencing with proprietary bioinformatics algorithms to differentiate pathogenic microbes from background microbial DNA.
Further Reading
- Five stocks we like better than Revelation Biosciences
- System Upgrade: First Internet Bancorp Options Surge
- AI Security Breaches Raise New Risks for Microsoft and Amazon’s Agent Push
- The AI Chip Blockade Is Creating a Shadow Market
- Grab Holdings Stock Forms Bottom After Strong Beat-and-Raise Quarter
Receive News & Ratings for Revelation Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Revelation Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
